Blagojevic Christina, Brown Kevin A, Diong Christina, Fridman Daniel J, Johnstone Jennie, Langford Bradley J, Lee Samantha M, MacFadden Derek R, Schwartz Kevin L, Daneman Nick
Internal Medicine Residency Program, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Open Forum Infect Dis. 2024 Dec 2;11(12):ofae712. doi: 10.1093/ofid/ofae712. eCollection 2024 Dec.
Antimicrobial-resistant (AMR) pathogens represent an ongoing global health burden. Colonization is often a prerequisite for infection, but the risk of infection after AMR colonization is not well understood. Using population-level health administrative data, we sought to investigate the risk of infection with the same AMR organism after detection of colonization.
We conducted a retrospective population-wide cohort study among residents of Ontario, Canada, over a 5-year period to determine the risk of infection after detection of colonization with the following AMR pathogens: methicillin-resistant , vancomycin-resistant , extended-spectrum β-lactamase-producing Enterobacterales, and carbapenemase-producing Enterobacterales. We also examined the effects of age, sex, and health care setting of colonization detection on subsequent infection risk.
There were 69 998 individuals with a positive AMR pathogen surveillance test result during the study period, 15.6% of which subsequently developed a sterile or nonsterile site infection within a median 57 days (IQR, 11-228). Infection rates varied among organisms: 18.3% for methicillin-resistant within a median 57 days (IQR, 10-239), 2.8% for vancomycin-resistant within a median 37 days (IQR, 11-119), 21.5% for extended-spectrum β-lactamase-producing Enterobacterales within a median 71 days (IQR, 18-231), and 20.3% for carbapenemase-producing Enterobacterales within a median 10 days (IQR, 3-42). A positive surveillance test result detected in a hospital was associated with increased infection risk after colonization as compared with the community setting.
The overall infection rate after colonization with an AMR pathogen was high for most organisms, highlighting the importance of detecting colonization from both an infection control and empiric antibiotic selection perspective.
抗菌药物耐药(AMR)病原体是持续存在的全球健康负担。定植通常是感染的先决条件,但AMR定植后感染的风险尚不清楚。我们利用人群水平的卫生行政数据,试图调查定植检测后感染同一种AMR病原体的风险。
我们在加拿大安大略省居民中进行了一项为期5年的回顾性全人群队列研究,以确定在检测到以下AMR病原体定植后感染的风险:耐甲氧西林金黄色葡萄球菌、耐万古霉素肠球菌、产超广谱β-内酰胺酶肠杆菌科细菌和产碳青霉烯酶肠杆菌科细菌。我们还研究了定植检测时的年龄、性别和医疗机构对后续感染风险的影响。
在研究期间,有69998人的AMR病原体监测检测结果呈阳性,其中15.6%的人在中位57天(四分位间距,11 - 228天)内随后发生了无菌部位或非无菌部位感染。不同病原体的感染率有所不同:耐甲氧西林金黄色葡萄球菌在中位57天(四分位间距,10 - 239天)内的感染率为18.3%,耐万古霉素肠球菌在中位37天(四分位间距,11 - 119天)内的感染率为2.8%,产超广谱β-内酰胺酶肠杆菌科细菌在中位71天(四分位间距,18 - 231天)内的感染率为21.5%,产碳青霉烯酶肠杆菌科细菌在中位10天(四分位间距,3 - 42天)内的感染率为20.3%。与社区环境相比,在医院检测到的阳性监测结果与定植后感染风险增加相关。
对于大多数病原体而言,AMR病原体定植后的总体感染率较高,这凸显了从感染控制和经验性抗生素选择角度检测定植的重要性。